NCT03027557 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Adverse events were collected for each participant from baseline until two weeks after treatment-cessation, up to 1 year.
- Other-event reporting threshold
- 5%
Adverse events were collected at each visit using a adverse event questionnaire as well as assessment by a study-physician.
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| Combined Treatment. | 2 / 15 | 13 / 15 | 0 / 15 |
| Denosumab Monotherapy | 1 / 16 | 15 / 16 | 0 / 16 |
| Placebo | 3 / 15 | 15 / 15 | 0 / 15 |
Serious adverse events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Angina, Unstable
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Polycythaemia Vera
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Epilepsy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Inflammatory Bowel Disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Erysipelas
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 7
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Leg edema
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 16
- num Events
- 9
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- term
- Coughing
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 6
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Dyspnea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 15
- num Events
- 36
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 16
- num Events
- 15
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 15
- num Events
- 20
- term
- Paraesthesia, hands
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 15
- num Events
- 17
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 16
- num Events
- 27
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 23
- term
- Paraesthesia, feet
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Headache
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 2
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 5
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 3
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 16
- num Events
- 7
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 15
- num Events
- 17
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 15
- num Events
- 18
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 16
- num Events
- 21
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 15
- num Events
- 5
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 6
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 6
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 15
- num Events
- 5
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 5
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Cystitis
Complete source fields
- description
- Adverse events were collected at each visit using a adverse event questionnaire as well as assessment by a study-physician.
- event Groups
- deaths Num Affected
- 0
- deaths Num At Risk
- 15
- description
- 15 subjects were treated with combined 60mg denosumab every six months, 30 mg cinacalcet daily and 50 micrograms vitamin-D3 daily.
- id
- EG000
- other Num Affected
- 13
- other Num At Risk
- 15
- serious Num Affected
- 2
- serious Num At Risk
- 15
- title
- Combined Treatment.
- deaths Num Affected
- 0
- deaths Num At Risk
- 16
- description
- 16 subjects received 60 mg denosumab every six months, placebo and 50 micrograms vitamin-D daily.
- id
- EG001
- other Num Affected
- 15
- other Num At Risk
- 16
- serious Num Affected
- 1
- serious Num At Risk
- 16
- title
- Denosumab Monotherapy
- deaths Num Affected
- 0
- deaths Num At Risk
- 15
- description
- 15 subjects will receive a saline injection every six months(blinded), placebo-tablets and 50 micrograms vitamin-D daily.
- id
- EG002
- other Num Affected
- 15
- other Num At Risk
- 15
- serious Num Affected
- 3
- serious Num At Risk
- 15
- title
- Placebo
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 7
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Leg edema
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 16
- num Events
- 9
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- term
- Coughing
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Respiratory, thoracic and mediastinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 6
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Dyspnea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 6
- num At Risk
- 15
- num Events
- 36
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 16
- num Events
- 15
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 15
- num Events
- 20
- term
- Paraesthesia, hands
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 15
- num Events
- 17
- group Id
- EG001
- num Affected
- 3
- num At Risk
- 16
- num Events
- 27
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 23
- term
- Paraesthesia, feet
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 4
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 1
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Headache
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- General disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 2
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 5
- term
- Fatigue
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Ear and labyrinth disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 3
- group Id
- EG001
- num Affected
- 4
- num At Risk
- 16
- num Events
- 7
- group Id
- EG002
- num Affected
- 3
- num At Risk
- 15
- num Events
- 17
- term
- Dizziness
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 7
- num At Risk
- 15
- num Events
- 18
- group Id
- EG001
- num Affected
- 9
- num At Risk
- 16
- num Events
- 21
- group Id
- EG002
- num Affected
- 4
- num At Risk
- 15
- num Events
- 5
- term
- Nausea
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 6
- group Id
- EG001
- num Affected
- 2
- num At Risk
- 16
- num Events
- 6
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Abdominal pain
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 3
- num At Risk
- 15
- num Events
- 5
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- term
- Gastroenteritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Renal and urinary disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 2
- num At Risk
- 15
- num Events
- 2
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 5
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Cystitis
- serious Events
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Cardiac disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Angina, Unstable
- assessment Type
- NON_SYSTEMATIC_ASSESSMENT
- organ System
- Blood and lymphatic system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Polycythaemia Vera
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Nervous system disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 1
- num At Risk
- 16
- num Events
- 1
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Epilepsy
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- term
- Inflammatory Bowel Disease
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Gastrointestinal disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Gastritis
- assessment Type
- SYSTEMATIC_ASSESSMENT
- organ System
- Skin and subcutaneous tissue disorders
- source Vocabulary
- MedDRA (Unspecified)
- stats
- group Id
- EG000
- num Affected
- 0
- num At Risk
- 15
- num Events
- 0
- group Id
- EG001
- num Affected
- 0
- num At Risk
- 16
- num Events
- 0
- group Id
- EG002
- num Affected
- 1
- num At Risk
- 15
- num Events
- 1
- term
- Erysipelas
- time Frame
- Adverse events were collected for each participant from baseline until two weeks after treatment-cessation, up to 1 year.
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle